(Q48381169)

11 February 2018

title

Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA. (English)

1 reference

11 February 2018

author name string

D Balériaux

series ordinal

1

1 reference

11 February 2018

C Matos

series ordinal

2

1 reference

11 February 2018

D De Greef

series ordinal

3

1 reference

11 February 2018

publication date

1 January 1993

1 reference

11 February 2018

published in

Neuroradiology

1 reference

11 February 2018

volume

35

1 reference

11 February 2018

issue

7

1 reference

11 February 2018

page(s)

490-494

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00588702

exact match

0 references

cites work

Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent

1 reference

https://api.crossref.org/works/10.1007%2FBF00588702

Spinal cord tumors: gadolinium-DTPA-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00588702

Safety of gadolinium-DTPA: Extended clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00588702

Ionic versus nonionic MR imaging contrast media: operational definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00588702

Preliminary clinical trial of gadodiamide injection: A new nonionic gadolinium contrast agent for MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00588702

Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00588702

Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00588702

Gadolinium-DOTA enhanced MR imaging of intracranial lesions

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FBF00588702

21 January 2018

12 December 2020

Generalized seizure after i.v. administration of gadopentetate dimeglumine

1 reference

12 December 2020

First use of GdDTPA/dimeglumine in man.

1 reference

12 December 2020

Case of anaphylaxis and four cases of allergic reaction following Gd-DTPA administration

1 reference

12 December 2020

Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings.

1 reference

12 December 2020

Assessment of extradural degenerative disease with Gd-DTPA-enhanced MR imaging: correlation with surgical and pathologic findings.

1 reference

12 December 2020

Gadolinium-enhanced MR in spinal infection

1 reference

12 December 2020

A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement Agent

1 reference

12 December 2020

Gd-DTPA in MR of spinal lesions

1 reference

12 December 2020

Safety assessment of gadopentetate dimeglumine in U.S. clinical trials

1 reference

12 December 2020

Anaphylactoid reactions to i.v. gadopentetate dimeglumine

1 reference

12 December 2020

Time-dependent changes in image contrast in brain tumors after gadolinium-DTPA.

1 reference

12 December 2020

New applications of MR contrast agents in neuroradiology

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00588702

1 reference

11 February 2018

1 reference

11 February 2018